European Journal of Chemistry 2012, 3(2), 228-234 | doi: https://doi.org/10.5155/eurjchem.3.2.228-234.596 | Get rights and content






  OPEN ACCESS | PEER-REVIEWED | RESEARCH ARTICLE | DOWNLOAD PDF | VIEW FULL-TEXT PDF | TOTAL VIEWS

In-vitro cytotoxic and radiosensitizing evaluation of novel 2-pyridone, isoquinoline, chromene and chromenopyridone derivatives


Mansour Sulaiman Al-Said (1) , Marwa Galal El-Gazzar (2) , Mostafa Mohammed Ghorab (3,*)

(1) Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia
(2) Department of Drug Radiation Research, National Center for Radiation Research and Technology, Nasr City, Cairo, 11371, Egypt
(3) Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia
(*) Corresponding Author

Received: 10 Feb 2012 | Revised: 16 Mar 2012 | Accepted: 28 Mar 2012 | Published: 30 Jun 2012 | Issue Date: June 2012

Abstract


On the account of the reported anticancer activity of 2-pyridone, a new series of ethyl-1,6-dihydropyridine-3-carboxylate (4a-j), 1-oxo-1,2-dihydroisoquinoline-7-carbonitrile (6a-h), 2H-chromene (7,8) and 3H-chromeno[3,4-c]pyridone derivatives (9,10) were synthesized and tested for in-vitro anticancer activity against Ehrlich Ascites Carcinoma (EAC) cell line and human liver cell line (HEPG2). The structures of the synthesized compounds were confirmed by analytical and spectral data. Furthermore, radiosensitization study was performed for the most potent compounds (4a, 4d, 6a, 6c, 6e and 10).

3_2_228_234_800


Keywords


Cytotoxic; Chromene; 2-Pyridone; Isoquinoline; Radiosensitizing; Chromenopyridone

Full Text:

PDF /    /


DOI: 10.5155/eurjchem.3.2.228-234.596

Links for Article


| | | | | | |

| | | | | | |

Related Articles




Article Metrics

This Abstract was viewed 968 times | PDF Article downloaded 304 times

Funding information


The Research Center, College of Pharmacy and the Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia

Citations

/


[1]. Satoshi Endo, Hiroaki Oguri, Jin Segawa, Mina Kawai, Dawei Hu, Shuang Xia, Takuya Okada, Katsumasa Irie, Shinya Fujii, Hiroaki Gouda, Kazuhiro Iguchi, Takuo Matsukawa, Naohiro Fujimoto, Toshiyuki Nakayama, Naoki Toyooka, Toshiyuki Matsunaga, Akira Ikari
Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate Cancer
Journal of Medicinal Chemistry  , , 2020
DOI: 10.1021/acs.jmedchem.0c00939
/


[2]. Govindarasu Murugavel, Tharmalingam Punniyamurthy
Novel Copper-Catalyzed Multicomponent Cascade Synthesis of Iminocoumarin Aryl Methyl Ethers
Organic Letters  15(15), 3828, 2013
DOI: 10.1021/ol4014359
/


[3]. S. Trichili, M. Kammoun, S. Abid, H. Ammar
Synthesis of New Benzopyrano[2,3-c]pyrazoles and 3-triazolonyliminocoumarins From 3-cyano Iminocoumarin Derivatives
Synthetic Communications  44(19), 2808, 2014
DOI: 10.1080/00397911.2014.903422
/


[4]. Mostafa Ghorab, Marwa El-Gazzar, Mansour Alsaid
Synthesis and Anti-Breast Cancer Evaluation of Novel N-(Guanidinyl)benzenesulfonamides
International Journal of Molecular Sciences  15(4), 5582, 2014
DOI: 10.3390/ijms15045582
/


[5]. Shivaputra A Patil, Renukadevi Patil, Lawrence M Pfeffer, Duane D Miller
Chromenes: potential new chemotherapeutic agents for cancer
Future Medicinal Chemistry  5(14), 1647, 2013
DOI: 10.4155/fmc.13.126
/


[6]. Pintu Kumar Mandal
Copper-catalyzed one-pot synthesis of glycosylated iminocoumarins and 3-triazolyl-2-iminocoumarins
RSC Advances  4(11), 5803, 2014
DOI: 10.1039/c3ra46844e
/


References

[1]. Abadi, A. H.; Ibrahim, T. M.; Abouzid, K. M.; Lehmann. J.; Tinsley, H. N.; Gary, B. D.; Piazza, G. A. Bioorg. Med. Chem. 2009, 17, 5974-5982.
http://dx.doi.org/10.1016/j.bmc.2009.06.063

[2]. Cheney, I. W.; Yan, S.; Appleby, T.; Walker, H.; Vo, T.; Yao, N.; Hamatake, R.; Hong, Z.; Wu, J. Z. Bioorg. Med. Chem. Lett. 2007, 17, 1679-1683.
http://dx.doi.org/10.1016/j.bmcl.2006.12.086

[3]. Wendt, M. D.; Sun, C.; Kunzer, A.; Sauer, D.; Sarris, K.; Hoff, E.; Yu, L.; Nettesheim, D. G.; Chen, J.; Jin, S.; Comess, K. M.; Fan, Y.; Anderson, S. N.; Isaac, B.; Olejniczak, E. T.; Hajduk, P. J.; Rosenberg, S. H.; Elmore, S. W. Bioorg. Med. Chem. Lett. 2007, 17, 3122-3129.
http://dx.doi.org/10.1016/j.bmcl.2007.03.042

[4]. Aqui, N. A.; Vonderheide, R. H. Cancer Biol. Ther. 2008, 7, 1888-1889.
http://dx.doi.org/10.4161/cbt.7.12.7219

[5]. Ambrosini, G.; Adida, C.; Altieri, D. C. Nat. Med. 1997, 3, 917-921.
http://dx.doi.org/10.1038/nm0897-917
PMid:9256286

[6]. Gary, P.; Soh, J. W.; Mao, Y.; Kim, M. G.; Pamukcu, R.; Li, H.; Piazza, G. A.; Thompson, W. J.; Weinstein, I. B. Clin. Cancer Res. 2000, 6, 4136-4141.
PMid:11051267

[7]. Alagille, D.; Baldwin, R. M.; Tamagnan, G. D. Tetrahedron Lett. 2004, 45, 6179-6181.
http://dx.doi.org/10.1016/j.tetlet.2004.06.007

[8]. Raj, T.; Bhatia, R. K.; Kapur, A.; Sharma, M.; Saxena, A. K.; Ishar, M. P. S. Eur. J. Med. Chem. 2010, 45, 790-794.
http://dx.doi.org/10.1016/j.ejmech.2009.11.001
PMid:19939522

[9]. Endo, S.; Matsunaga, T.; Kuwata, K.; Zhao, H. T.; El-Kabbani, O.; Kitade, Y.; Hara, A. Bioorg. Med. Chem. 2010, 18, 2485-2490.
http://dx.doi.org/10.1016/j.bmc.2010.02.050

[10]. Sabry, N. M.; Mohamed, H. M.; Shawky, E.; Khattab, A. E. H.; Motlaq, S. S.; El-Agrody, A. M. Eur. J. Med. Chem. 2011, 46, 765-772.
http://dx.doi.org/10.1016/j.ejmech.2010.12.015
PMid:21216502

[11]. Ghorab, M. M.; Ragab, F. A.; Hamed, M. M. Eur. J. Med. Chem. 2009, 44, 4211-4217.
http://dx.doi.org/10.1016/j.ejmech.2009.05.017
PMid:19540022

[12]. Al-Said, M. S.; Ghorab, M. M.; Al-Qasoumi, S. I.; El-Hossary, E. M.; Noaman, E. Eur. J. Med. Chem. 2010, 45, 3011-3018.
http://dx.doi.org/10.1016/j.ejmech.2010.03.030
PMid:20413187

[13]. Al-Qasoumi, S. I.; Al-Taweel, A. M.; Alafeey, A. M.; Ghorab, M. M.; Noaman, E. Bioorg. Med. Chem. Lett. 2009, 19, 6939-6942.
http://dx.doi.org/10.1016/j.bmcl.2009.10.065

[14]. Ghorab, M. M.; Ragab, F. A.; Al-Qasoumi, S. I.; Alafeefy, A. M.; Aboulmagd, S. A. Eur. J. Med. Chem. 2010, 45, 171-178.
http://dx.doi.org/10.1016/j.ejmech.2009.09.039
PMid:19853327

[15]. Al-Qasoumi, S. I.; Al-Taweel, A. M.; Al-Afeefy, A. M.; Noaman, E.; Ghorab, M. M. Eur. J. Med. Chem. 2010, 45, 738-744.
http://dx.doi.org/10.1016/j.ejmech.2009.11.021
PMid:19944497

[16]. Al-Qasoumi, S. I.; Al-Taweel, A. M.; Alafeefy, A. M.; Ghorab, M. M.; Noaman, E. Eur. J. Med. Chem. 2010, 45, 1849-1853.
http://dx.doi.org/10.1016/j.ejmech.2010.01.022
PMid:20149941

[17]. Devi, P. U.; Solomon, F. E.; Sharada, A. C. Pharm. Biol. 1999, 37(3), 231-236.
http://dx.doi.org/10.1076/phbi.37.3.231.6299

[18]. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
http://dx.doi.org/10.1093/jnci/82.13.1107

[19]. Nishimura, Y. Int. J. Clin. Oncol. 2004, 9, 414-420.
http://dx.doi.org/10.1007/s10147-004-0443-z
PMid:15616871

How to cite


Al-Said, M.; El-Gazzar, M.; Ghorab, M. Eur. J. Chem. 2012, 3(2), 228-234. doi:10.5155/eurjchem.3.2.228-234.596
Al-Said, M.; El-Gazzar, M.; Ghorab, M. In-vitro cytotoxic and radiosensitizing evaluation of novel 2-pyridone, isoquinoline, chromene and chromenopyridone derivatives. Eur. J. Chem. 2012, 3(2), 228-234. doi:10.5155/eurjchem.3.2.228-234.596
Al-Said, M., El-Gazzar, M., & Ghorab, M. (2012). In-vitro cytotoxic and radiosensitizing evaluation of novel 2-pyridone, isoquinoline, chromene and chromenopyridone derivatives. European Journal of Chemistry, 3(2), 228-234. doi:10.5155/eurjchem.3.2.228-234.596
Al-Said, Mansour, Marwa Galal El-Gazzar, & Mostafa Mohammed Ghorab. "In-vitro cytotoxic and radiosensitizing evaluation of novel 2-pyridone, isoquinoline, chromene and chromenopyridone derivatives." European Journal of Chemistry [Online], 3.2 (2012): 228-234. Web. 23 Sep. 2020
Al-Said, Mansour, El-Gazzar, Marwa, AND Ghorab, Mostafa. "In-vitro cytotoxic and radiosensitizing evaluation of novel 2-pyridone, isoquinoline, chromene and chromenopyridone derivatives" European Journal of Chemistry [Online], Volume 3 Number 2 (30 June 2012)

The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item


DOI Link: https://doi.org/10.5155/eurjchem.3.2.228-234.596

| | | | | | |

| | | | | |

Save to Zotero Save to Mendeley



European Journal of Chemistry 2012, 3(2), 228-234 | doi: https://doi.org/10.5155/eurjchem.3.2.228-234.596 | Get rights and content

Refbacks

  • There are currently no refbacks.




Copyright (c)




© Copyright 2010 - 2020  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2010-2020 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.